Please login to the form below

Not currently logged in
Email:
Password:

Probuphine

This page shows the latest Probuphine news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant. Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... It found that 63% of patients treated with the Probuphine implant had no evidence of illicit opioid use throughout

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    FDA panel backs approval of first opioid addiction implant. Probuphine has been developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a particular focus on the Probuphine

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics